{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:58Z","timestamp":1790223418459,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,7]],"date-time":"2014-12-07T00:00:00Z","timestamp":1417910400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00403-014-1527-x","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T14:29:07Z","timestamp":1418048947000},"page":"479-485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Analysis of the IL-31 pathway in Mycosis fungoides and S\u00e9zary syndrome"],"prefix":"10.1007","volume":"307","author":[{"given":"Markus","family":"M\u00f6bs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Gryzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Haidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Humme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Vandersee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,7]]},"reference":[{"key":"1527_CR1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4161\/cbt.12.12.18144","volume":"12","author":"RM Abraham","year":"2011","unstructured":"Abraham RM, Zhang Q, Odum N, Wasik MA (2011) The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma. Cancer Biol Ther 12:1019\u20131022","journal-title":"Cancer Biol Ther"},{"key":"1527_CR2","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","volume":"28","author":"NS Agar","year":"2010","unstructured":"Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S et al (2010) Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 28:4730\u20134739","journal-title":"J Clin Oncol"},{"key":"1527_CR3","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/jid.2012.125","volume":"132","author":"N Al-Yacoub","year":"2012","unstructured":"Al-Yacoub N, Fecker LF, M\u00f6bs M, Pl\u00f6tz M, Braun FK, Sterry W et al (2012) Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling. J Invest Dermatol 132:2263\u20132274","journal-title":"J Invest Dermatol"},{"key":"1527_CR4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaci.2005.10.046","volume":"117","author":"J Bilsborough","year":"2006","unstructured":"Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, Yao L et al (2006) IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 117:418\u2013425","journal-title":"J Allergy Clin Immunol"},{"key":"1527_CR5","first-page":"433","volume":"3","author":"TP Chang","year":"2013","unstructured":"Chang TP, Vancurova I (2013) NF\u03baB function and regulation in cutaneous T-cell lymphoma. Am J Cancer Res 3:433\u2013445","journal-title":"Am J Cancer Res"},{"key":"1527_CR6","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/cncr.22252","volume":"107","author":"MF Demierre","year":"2006","unstructured":"Demierre MF, Gan S, Jones J, Miller DR (2006) Significant impact of cutaneous T-cell lymphoma on patients\u2019 quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey. Cancer 107:2504\u20132511","journal-title":"Cancer"},{"key":"1527_CR7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","volume":"5","author":"SR Dillon","year":"2004","unstructured":"Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR et al (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5:752\u2013760","journal-title":"Nat Immunol"},{"key":"1527_CR8","doi-asserted-by":"crossref","first-page":"49850","DOI":"10.1074\/jbc.M307286200","volume":"278","author":"C Diveu","year":"2003","unstructured":"Diveu C, Leli\u00e8vre E, Perret D, Lak-Hal AH, Froger J, Guillet C et al (2003) GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptor. J Biol Chem 278:49850\u201349859","journal-title":"J Biol Chem"},{"key":"1527_CR9","doi-asserted-by":"crossref","first-page":"36112","DOI":"10.1074\/jbc.M401122200","volume":"279","author":"A Dreuw","year":"2004","unstructured":"Dreuw A, Radtke S, Pflanz S, Lippok BE, Heinrich PC, Hermanns HM (2004) Characterization of the signaling capacities of the novel gp130-like cytokine receptor. J Biol Chem 279:36112\u201336120","journal-title":"J Biol Chem"},{"key":"1527_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/all.12316","volume":"69","author":"T Hawro","year":"2014","unstructured":"Hawro T, Saluja R, Weller K, Altrichter S, Metz M, Maurer M (2014) Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge. Allergy 69:113\u2013117","journal-title":"Allergy"},{"key":"1527_CR11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(08)60420-1","volume":"371","author":"ST Hwang","year":"2008","unstructured":"Hwang ST, Janik JE, Jaffe ES, Wilson WH (2008) Mycosis fungoides and S\u00e9zary syndrome. Lancet 371:945\u2013957","journal-title":"Lancet"},{"key":"1527_CR12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3109\/10428194.2012.729831","volume":"54","author":"MH Imam","year":"2013","unstructured":"Imam MH, Shenoy PJ, Flowers CR, Phillips A, Lechowicz MJ (2013) Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leuk Lymphoma 54:752\u2013759","journal-title":"Leuk Lymphoma"},{"key":"1527_CR13","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1093\/bioinformatics\/btn523","volume":"24","author":"R Joehanes","year":"2008","unstructured":"Joehanes R, Nelson JC (2008) QGene 4.0, an extensible Java QTL-analysis platform. Bioinformatics 24:2788\u20132789","journal-title":"Bioinformatics"},{"key":"1527_CR14","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/jid.2010.8","volume":"130","author":"E Laharanne","year":"2010","unstructured":"Laharanne E, Oumouhou N, Bonnet F, Carlotti M, Gentil C, Chevret E et al (2010) Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. J Invest Dermatol 130:1707\u20131718","journal-title":"J Invest Dermatol"},{"key":"1527_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-3083.1990.tb02778.x","volume":"31","author":"CS Larsen","year":"1990","unstructured":"Larsen CS (1990) Activation of human T lymphocytes by phorbol-12,13-dibutyrate and ionomycin. Scand J Immunol 31:353\u2013360","journal-title":"Scand J Immunol"},{"key":"1527_CR16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1600-0560.2007.00924.x","volume":"35","author":"X Mao","year":"2008","unstructured":"Mao X, Orchard G, Mitchell TJ, Oyama N, Russell-Jones R, Vermeer MH et al (2008) A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS. J Cutan Pathol 35:899\u2013910","journal-title":"J Cutan Pathol"},{"key":"1527_CR17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/cyto.1996.0044","volume":"8","author":"RM Marti","year":"1996","unstructured":"Marti RM, Wasik MA, Kadin ME (1996) Constitutive secretion of GM-CSF by three different cell lines derived from a single patient with a progressive cutaneous lymphoproliferative disorder. Cytokine 8:323\u2013329","journal-title":"Cytokine"},{"key":"1527_CR18","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1111\/j.1468-3083.2012.04495.x","volume":"27","author":"T Miyagaki","year":"2013","unstructured":"Miyagaki T, Sugaya M, Suga H, Ohmatsu H, Fujita H, Asano Y et al (2013) Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis. J Eur Acad Dermatol Venereol 27:e60\u2013e67","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1527_CR19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2340\/00015555-1191","volume":"92","author":"S Nobbe","year":"2012","unstructured":"Nobbe S, Dziunycz P, M\u00fchleisen B, Bilsborough J, Dillon SR, French LE, Hofbauer GF (2012) IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. Acta Derm Venereol 92:24\u201328","journal-title":"Acta Derm Venereol"},{"key":"1527_CR20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2340\/00015555-1345","volume":"92","author":"H Ohmatsu","year":"2012","unstructured":"Ohmatsu H, Sugaya M, Suga H, Morimura S, Miyagaki T, Kai H et al (2012) Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma. Acta Derm Venereol 92:282\u2013283","journal-title":"Acta Derm Venereol"},{"key":"1527_CR21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2133.2003.05224.x","volume":"148","author":"E Papadavid","year":"2003","unstructured":"Papadavid E, Economidou J, Psarra A, Kapsimali V, Mantzana V, Antoniou C et al (2003) The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and S\u00e9zary syndrome. Br J Dermatol 148:709\u2013718","journal-title":"Br J Dermatol"},{"key":"1527_CR22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1084\/jem.20061791","volume":"204","author":"JG Perrigoue","year":"2007","unstructured":"Perrigoue JG, Li J, Zaph C, Goldschmidt M, Scott P, de Sauvage FJ (2007) IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung. J Exp Med 204:481\u2013487","journal-title":"J Exp Med"},{"key":"1527_CR23","first-page":"62","volume":"8","author":"E Ralfkiaer","year":"1991","unstructured":"Ralfkiaer E (1991) Immunohistological markers for the diagnosis of cutaneous lymphomas. Semin Diagnost Pathol 8:62\u201372","journal-title":"Semin Diagnost Pathol"},{"key":"1527_CR24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.cmr.0000382785.44182.38","volume":"20","author":"M Siakantari","year":"2010","unstructured":"Siakantari M (2010) Classification and molecular pathogenesis of CTCL. Melanoma Res 20:20\u201321","journal-title":"Melanoma Res"},{"key":"1527_CR25","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/jid.2013.227","volume":"133","author":"EM Singer","year":"2013","unstructured":"Singer EM, Shin DB, Nattkemper LA, Benoit BM, Klein RS, Didigu CA et al (2013) IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus. J Invest Dermatol 133:2783\u20132785","journal-title":"J Invest Dermatol"},{"key":"1527_CR26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5114\/pdia.2013.38356","volume":"30","author":"K Siniewicz-Luze\u0144czyk","year":"2013","unstructured":"Siniewicz-Luze\u0144czyk K, Sta\u0144czyk-Przy\u0142uska A, Zeman K (2013) Correlation between serum interleukin-31 level and the severity of disease in children with atopic dermatitis. Postepy Dermatol Alergol 30:282\u2013285","journal-title":"Postepy Dermatol Alergol"},{"key":"1527_CR27","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20101785","volume":"208","author":"A Steininger","year":"2011","unstructured":"Steininger A, M\u00f6bs M, Ullmann R, K\u00f6chert K, Kreher S, Lamprecht B et al (2011) Genomic loss of the putative tumor suppressor gene E2A in human lymphoma. J Exp Med 208:1585\u20131593","journal-title":"J Exp Med"},{"key":"1527_CR28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0625.2012.01487.x","volume":"21","author":"K Szegedi","year":"2012","unstructured":"Szegedi K, Kremer AE, Kezic S, Teunissen MB, Bos JD, Luiten RM et al (2012) Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp Dermatol 21:431\u2013436","journal-title":"Exp Dermatol"},{"key":"1527_CR29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-4632.2011.05188.x","volume":"51","author":"A Vij","year":"2012","unstructured":"Vij A, Duvic M (2012) Prevalence and severity of pruritus in cutaneous T cell lymphoma. Int J Dermatol 51:930\u2013934","journal-title":"Int J Dermatol"},{"key":"1527_CR30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","volume":"103","author":"BR Vowels","year":"1994","unstructured":"Vowels BR, Lessin SR, Cassin M, Jaworsky C, Benoit B, Wolfe JT, Rook AH (1994) Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 103:669\u2013673","journal-title":"J Invest Dermatol"},{"key":"1527_CR31","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768\u20133785","journal-title":"Blood"},{"key":"1527_CR32","first-page":"354","volume":"90","author":"R Willemze","year":"1997","unstructured":"Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S et al (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354\u2013371","journal-title":"Blood"},{"key":"1527_CR33","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/jid.2008.138","volume":"128","author":"C Zhang","year":"2008","unstructured":"Zhang C, Li B, Gaikwad AS, Haridas V, Xu Z, Gutterman JU, Duvic M (2008) Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells. J Invest Dermatol 128:2728\u20132735","journal-title":"J Invest Dermatol"},{"key":"1527_CR34","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/jid.2010.86","volume":"130","author":"C Zhang","year":"2010","unstructured":"Zhang C, Li B, Zhang X, Hazarika P, Aggarwal BB, Duvic M (2010) Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients\u2019 PBMCs: potential role for STAT-3 and NF-kappaB signaling. J Invest Dermatol 130:2110\u20132119","journal-title":"J Invest Dermatol"},{"key":"1527_CR35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cytogfr.2008.08.003","volume":"19","author":"Q Zhang","year":"2008","unstructured":"Zhang Q, Putheti P, Zhou Q, Liu Q, Gao W (2008) Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev 19:347\u2013356","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-014-1527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-014-1527-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-014-1527-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:39:57Z","timestamp":1559065197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-014-1527-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,7]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1527"],"URL":"https:\/\/doi.org\/10.1007\/s00403-014-1527-x","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,7]]}}}